comfort inn langley bc

Phyto Extractions Inc. Officially Launches Shatter For Adult-Use Market

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(FRA:D2EP) ("Phyto Extractions™or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Shatter is Phyto Extractions™ newest product category, with three new high THC extract offerings produced from single-source strains (local to BC and ON). Available in three highly popular strains including: Blue Gorilla OG, Pink Kush and D Bubba, all Phyto Extractions™ shatter is extracted and processed in a controlled laboratory environment to prevent contaminants, living up to the brands promise of offering consumers products that are free of additives and synthetic fillers

In partnership with Namaste Technologies Inc. subsidiary, CannMart Inc., Phyto Extractions™ shatter is now available through licensed adult-use retailers in British Columbia, Saskatchewan and Manitoba. Strain availability currently varies in each provincial distributor and private store. Pink Kush and D Bubba have been selected in British Columbia. All three SKUs; Blue Gorilla OG, D Bubba and Pink Kush are available in Saskatchewan and Manitoba.

Blue Gorilla OG is a rare hybrid of the Glueberry OG and Blue Gorilla, creating a memorable, euphoric effect that will "stick like glue". This flavour boasts over 70% of THC content and flavour notes of blueberry and pine wood. D Bubba is the close sibling of the former, with 73.9% of THC and a distinctly dank smell imbued within, thanks to the hybrid plant-types of Death Star and Bubba Kush. Phyto Extractions™ shatter is also available in the classic Pink Kush variety, sure to entice users with a pleasantly sweet taste and robust THC content.

This is just the start of Phyto's shatter product line, with more exciting flavours already in development. Phyto Extractions™' shatter products are extracted using the latest hydrocarbon extraction systems in the industry, with output capacity of over 50KG of product per day and further plans to expand its capabilities and new product offerings for cannabis enthusiasts Canada wide.

"Bringing high quality shelf stable shatter to the Canadian adult-use market, for a competitive price is a massive milestone for Phyto Extractions. Shatter is so fundamental to who we are as a company and we can't wait to share it with consumers," said Donald Dinsmore, COO, Phyto Extractions Inc.

To learn more about how Phyto Extractions™ shatter is made, please watch the following video: https://youtu.be/bMz4V_WVoLI

About Phyto Extractions™

Phyto Extractions™ is an agricultural-scale cannabis extraction, distillation and product manufacturer located in Langley, BC at its co-located Health Canada Licensed Standard Processing (extraction and products, no cultivation), Sales (extracts, topicals, and edibles), and R&D through Adastra Labs Inc. and Analytical Testing Laboratory through Chemia Analytics Inc.

ON BEHALF OF THE BOARD

Phyto Extractions Inc. (CSE:XTRX)

CONTACT:
Michael Forbes, President, CEO & Director (Chairman)
Phone: 778-715-5011
Email: michael@phytoextractions.ca

About Namaste Technologies Inc.

CannMart Inc., a subsidiary of Namaste Technologies Inc. (N)(NXTTF), is a licensed entity, with a desktop and mobile portal that provides cannabis patients access to authorized and vetted medical cannabis products across Canada. CannMart medical patients are easily able to purchase Phyto Extractions products from the comfort of their home and have them delivered directly to their door once they have received their medical document.

Information on the Company and its many products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
Cannmart.com

For more information please contact:

Namaste Technologies Inc.
Meni Morim, CEO
Edward Miller, VP Investor Relations
Ph: 647-362-0390
Email: ir@namastetechnologies.com

Forward-Looking Information:

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking information in this news release includes statements with respect of the proposed name change, proposed consolidation, the closing of the private placement and the use of proceeds thereof. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward looking information, including: (i) adverse market conditions; (ii) risks inherent in the cannabis extraction sector in general; (iii) inability to close the private placement for any reason, or in the amounts expected by the Company; and (iv) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements. The CSE has not reviewed or approved of any contents of this news release.

SOURCE: Phyto Extractions Inc.



View source version on accesswire.com:
https://www.accesswire.com/649997/Phyto-Extractions-Inc-Officially-Launches-Shatter-For-Adult-Use-Market

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Jacksonville, Florida

New Duval County location will host grand opening celebration Friday, December 6 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Jacksonville, Florida on Saturday, November 23 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Cannabis Corp. Announces Insider Share Purchases By Executive Leadership and Board Members

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that several members of its executive management team and board of directors have recently made purchases of the company's subordinate voting shares, signaling their confidence in the company's growth potential and direction.

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Between November 8, 2024 and November 21, 2024 , Chairman and CEO Kim Rivers , Director Thad Beshears , Director Peter Healy , Director Richard May , Director Thomas Milner , Director Jane Morreau , Director Susan Thronson , Chief Marketing Officer Gina Collins , Chief Technology Officer Nilyum Jhala, Chief Production Officer Kyle Landrum , Chief Information Officer Jason Pernell , Chief Legal Officer Eric Powers , Chief Operating Officer Marie Zhang , and Vice President of Investor Relations Christine Hersey purchased a total of 72,273 shares at prices between $5.63 and $7.19 per share. These insider purchases reflect the confidence and commitment of leadership in the long-term strategic plan for Trulieve and its shareholders.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve _
X: @Trulieve

Investor Contact  
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact  
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-cannabis-corp-announces-insider-share-purchases-by-executive-leadership-and-board-members-302313784.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2024/22/c2393.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×